NCT06769529 Observational Cohort Study of Adult Patients With Congenital Heart Disease
| NCT ID | NCT06769529 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Adult Congenital Heart Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2024-04-18 |
| Primary Completion | 2025-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2024-04-18 with a primary completion date of 2025-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this retrospective and prospective single-center observational study is to evaluate the correct management of adult patients with congenital heart diseas (ACHD), based on the experience of a reference center such as the Institute of Pediatric Cardiology at Policlinico Sant'Orsola Malpighi. The patients participating in this study will not be subjected to any procedures beyond normal daily clinical practice; likewise, the clinical variables that will be collected for the study are those that are commonly collected by the physician in daily clinical practice. This study therefore involves naturalistic observation of current clinical practice without the application of any kind of intervention.
Eligibility Criteria
Inclusion Criteria: * Patients with congenital heart disease in natural history or previously undergoing palliative or corrective surgery in the time period after 14/02/2014 * Obtaining informed consent Exclusion Criteria: * Age \< 18 years * Inability to obtain longitudinal data after the first follow-up performed at our Center.
Contact & Investigator
Gabriele Egidy Assenza, MD
PRINCIPAL INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Frequently Asked Questions
Who can join the NCT06769529 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Adult Congenital Heart Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06769529 currently recruiting?
Yes, NCT06769529 is actively recruiting participants. Contact the research team at gabriele.egidyassenza@aosp.bo.it for enrollment information.
Where is the NCT06769529 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT06769529 clinical trial?
NCT06769529 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Gabriele Egidy Assenza, MD at IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 2,000 participants.